Hepatic steatosis with significant fibrosis is associated with an increased 10-year estimated risk of cardiovascular disease in adults with type 1 diabetes mellitus

MLA

Mantovani, A., et al. Hepatic Steatosis with Significant Fibrosis Is Associated with an Increased 10-Year Estimated Risk of Cardiovascular Disease in Adults with Type 1 Diabetes Mellitus. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1415731571&authtype=sso&custid=ns315887.

APA

Mantovani, A., Morieri, M., Palmisano, L., Masulli, M., Cossu, E., Baroni, M., Bonomo, K., Cimini, F., Cavallo, G., Buzzetti, R., Mignogna, C., Leonetti, F., Bacci, S., Trevisan, R., Pollis, R., Aldigeri, R., Cas, A., de Kreutzenberg, S., Targher, G., … Targher, G. (2023). Hepatic steatosis with significant fibrosis is associated with an increased 10-year estimated risk of cardiovascular disease in adults with type 1 diabetes mellitus.

Chicago

Mantovani, A, M Morieri, L Palmisano, M Masulli, E Cossu, M Baroni, K Bonomo, et al. 2023. “Hepatic Steatosis with Significant Fibrosis Is Associated with an Increased 10-Year Estimated Risk of Cardiovascular Disease in Adults with Type 1 Diabetes Mellitus.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1415731571&authtype=sso&custid=ns315887.